BDBM696508 US20240307386, Compound Formula A

SMILES CN1CCN2C3CCN(CCCC(=O)c4ccc(F)cc4)CC3c3cccc1c23

InChI Key InChIKey=HOIIHACBCFLJET-UHFFFAOYSA-N

Data  5 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 696508   

Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM696508(US20240307386, Compound Formula A)
Affinity DataKi:  10nMAssay Description:In general, the results are expressed as a percent of control specific binding: measured⁢specific⁢bindingcontrol⁢specific⁢bin...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent

TargetD(1A) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM696508(US20240307386, Compound Formula A)
Affinity DataKi:  16nMAssay Description:In general, the results are expressed as a percent of control specific binding: measured⁢specific⁢bindingcontrol⁢specific⁢bin...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM696508(US20240307386, Compound Formula A)
Affinity DataKi:  41nMAssay Description:In general, the results are expressed as a percent of control specific binding: measured⁢specific⁢bindingcontrol⁢specific⁢bin...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM696508(US20240307386, Compound Formula A)
Affinity DataKi:  49nMAssay Description:In general, the results are expressed as a percent of control specific binding: measured⁢specific⁢bindingcontrol⁢specific⁢bin...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM696508(US20240307386, Compound Formula A)
Affinity DataKi: >1.00E+4nMAssay Description:In general, the results are expressed as a percent of control specific binding: measured⁢specific⁢bindingcontrol⁢specific⁢bin...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent